INTRODUCTION
The liver is one of the major metabolizing organs in the human body. It plays a pivotal role in providing important nutrients from the food to the blood. Changes in liver function due to infection or any other associated diseases, causes an imbalance in the above-mentioned functions leading to irreversible severe hepatic diseases/disorders, such as, liver cirrhosis, liver cancer, hepatitis, and the like.
[1] A large number of liver-associated disorders or diseases are still unknown. [2] [3] [4] [5] One of the most severe and common liver disease is attributed to Hepatitis, which occurs due to infl ammation caused by different types of hepatitis viruses. Hepatitis B and C lead to chronic disease in hundreds of millions of people; they are the most common cause of liver cirrhosis and cancer. [6] As per the World Health Organization (WHO) fact sheet, there are an estimated 1.4 million cases of hepatitis globally every year; [7] two billion people worldwide have been infected, and about 600 000 people die every year due to the consequences of Hepatitis B.
[8] About 150 million people are chronically infected, and more than 350 000 people die every year from Hepatitis C-related liver diseases.
[9] Every year there are 20 million Hepatitis E infections, over three million acute cases of Hepatitis E, and 70 000 hepatitis E-related deaths. [10] In India, about 250 000 people die of viral hepatitis, [11] [12] cirrhosis, about 20 000 liver cancers may be occurring annually, [13] and the community prevalence of nonalcoholic fatty liver diseases varies from 5 to 28%. [14] According to the latest WHO data published in April 2011, liver disease deaths in India reached 208 185 or 2.31% of the total deaths. The age-adjusted death rate is 23.59 per 100 000 of the population, which ranks India as twenty-seventh in the world. [15] It is estimated that liver diseases are among the top ten killer diseases in India. Many studies have reported that liver-related diseases like Hepatitis B and Hepatitis C virus could multiply into an epidemic that is greater than HIV.
In India, few non-profi table organizations play a signifi cant role in the prevention and treatment of liver diseases. The Indian Association for Study of the Liver (INASL) [16] fulfi lls the educational and scientifi c needs of many health professionals, as well as, researchers and basic scientists. The National Liver Foundation (NLF) [17] is involved in promoting awareness about preventable hepatic diseases among people suffering from chronic or advanced diseases through various educational and training programs, including seminars, patient support groups, mobilizing funds for providing treatment to patients at considerably subsidized rates, campaigns for promoting organ donation, and other activities such as vaccinating all medical students and paramedical entrants with the Hepatitis B vaccine. The Liver Care Foundation [18] works at the national level with patients, caregivers, and professionals associated with a liver disease.
There are few studies conducted on hepatitis and liver transplantation. Miri, Raoofi , and Heidari [19] evaluated the citation parameters of 104 articles published in the Hepatitis Monthly, in 2010, and covered three databases, including Web of Science, Scopus, and Google Scholar. Carvalho and Araújo [20] made a bibliographic study of the thesis published during 2000-2006, focusing on Hepatitis B, to identify where the studies had been undertaken, their nature, type, and the emphasis of these studies. Trapero, Pérez, Pajares, and Moreno [21] analyzed 1051 scientifi c publications on Hepatitis C virus infection, derived from the Medline database of Spanish hospitals, from 1980-2002. It noticed that the number and impact factor of scientifi c publications on Hepatitis C virus had grown signifi cantly during the last two decades. Bas, Dayangac Yaprak, Yuzer, and Tokat [22] studied the Turkish publications on liver transplantation from 1980 to 2011, as covered by the Science Citation Index (SCI). Ramakrishnan and Babu [23] studied world literature on hepatitis during the period 1984-2003, as covered in three bibliographic databases. It found that 85.17% of the contributions were collaborative in nature, with different degrees of collaborations. However, no specifi c studies have been undertaken in India on liver disorder research. Nevertheless, authors have carried out similar studies on other diseases in the Indian context, such as, tuberculosis, [24] malaria, [25] asthma, [26] measles, [27] and diabetes.
[28]
OBJECTIVES
The main objective of this study is to analyze the liver disorder research output in India during [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . The study has the following objectives:
1. To study the contribution and citation impact of 20 of the most productive countries, 2. To study India's overall contribution, its growth pattern, and citation impact, 3. To study the share of international collaboration in India's overall research output and the identifi cation and contribution of leading countries, 4. To study the Indian contribution and impact of different types of liver diseases, liver disorder researches by subfi elds and by different age groups, 5. To study the productivity and impact of leading Indian institutions and authors, and 6. To study the pattern of communication of the Indian output in the most productive journals. 
MATERIALS AND METHODS

RESULTS
Global publication share and rank
The global publication share of the top 20 most productive countries in liver disorder research varies from 0.88 to 25.55% during 2003-2012. The United States tops the list, with a publication share of 25.55% during [2003] [2004] [2005] [2006] [2007] [2008] [2009] [2010] [2011] [2012] . China ranks at the second position with a 11.67% publication share, followed by Japan (10.88% share, third rank), Italy (6.62% share, fourth rank), Germany (6.21% share, fi fth rank), U.K. (5.23% share, sixth rank), France (5.09% share, seventh rank), Spain, South Korea, Taiwan, Canada, and India with publication shares ranging from 2.19 to 3.86% and ranking from eighth to twelfth positions. Australia, Turkey, Switzerland, Brazil, Belgium, Greece, Poland, and Austria rank from the thirteenth to twentieth positions, with publication shares ranging from 0.88 to 1.98%. The developed countries showing an increase in their publication share are Italy by 0.43%, followed by Switzerland (0.28%), U. Among the 18 collaborating countries, the publication share has increased by 4.95% in Singapore, followed by Japan (4.36%), Spain (3.89%), South Korea (3.15%), Belgium (2.57%), France (2.28%), Australia (1.83%), Saudi Arabia (1.75%), Canada (1.50%), Malaysia In terms of the h-index, biochemistry, genetics, and molecular biology have achieved the highest h-index of 51, followed by medicine (44), pharmacology, toxicology, and pharmaceutics (35), immunology and microbiology (20) , and so on. On the basis of high-cited articles, biochemistry, genetics, and molecular biology depict the highest number of high-cited articles as nine, followed by medicine (fi ve), pharmacology, toxicology, and pharmaceutics (three), and chemistry (one) [ Table 4 ].
Indian research output by different types of liver disorder
Among the various types of liver disorders in India, the largest number of articles was on viral hepatitis (1286 articles, 54.03% publication share), followed by liver cancer (729 articles, 30.63% share), fatty liver disorder (496 articles, 20.84% share), autoimmune Table 5 ]. Within viral hepatitis, the largest emphasis was on hepatitis A (1096 articles), followed by hepatitis B (599 articles), hepatitis C (457 articles), drug-or toxic-induced hepatitis (308 articles), hepatitis E (287 articles), hepatitis D (104 articles), alcoholic hepatitis (89 articles), hepatitis delta virus (27 articles), and hepatitis G virus (five articles). Among liver cancer disorders, the maximum emphasis was on liver cell cancer (668 articles), squamous cell carcinoma (80 articles), cholangiocarcinoma and hepatoblastoma (28 articles each), angiosarcoma (11 articles), fi brolamellar carcinoma (six articles) and epithelial hemangioendothelioma (one article). Among autoimmune liver disorders, the largest emphasis was on autoimmune hepatitis (70 articles), followed by primary sclerosing cholanoitis (15 articles), and biliary cirrhosis (fi ve articles). Among genetic liver disorders, the largest emphasis was on Wilson disease (73 articles), followed by glycogen storage disease (30 articles), hemochromatosis (23 articles), tyrosinemia (eight articles) and alpha 1 antitrypsin defi ciency (seven articles) [ Table 6 ].
Lliver disorder research in india by type of population group
In the liver disorder research in India on population by age group, the largest emphasis was on adults (740 articles, 31.09% share), followed by the middle-aged (365 articles, 15.34% share), aged (227 articles, 9.54% share), adolescent (223 articles, 9.37% share), and child (212 articles, 8.91% share) [ Table 7 ].
Research profi le of the most productive indian institutions in liver disorder research in india
The Table 8 .
Only six institutions have registered a higher publication share than the group average productivity. These are All India Institute of Medical Sciences, New Delhi, with 155 articles, followed In conclusion it can be stated that the liver diseases are among the top ten killer diseases in India. Besides, those who suffer from chronic liver problems need recurrent hospitalization and prolonged medical attention. There are millions of cases of hepatic diseases that go unreported. Moreover, increasing poverty coupled with lack of education and awareness prevents people from seeking medical advice until it is too late. In addition, the high cost of treatment causes major obstacles in convincing people about taking treatment. Control strategies must include development of mass awareness programs, development of universal guidelines for immunization, and hygienic handling of food and water, which can reduce the liver disease burden substantially in our country. There is a growing need for the government of India to focus on promoting partnerships, mobilizing resources, evidence-based policy, data for action, prevention of transmission, introduction of universal HBV vaccination, free testing and government funding for liver transplantation. Besides this, there is a need to undertake more R and D, develop trained manpower at different levels, and create suffi cient infrastructure to handle the problems associated with liver disorder.
